- Cone-Beam Computed Tomography Perfusion allows for more insights to support clear diagnosis and precise treatment of stroke patients
- Collaboration supports the vision of angio-only approach for precise and timely stroke care
- Method supports immediate assessment of tissue viability during and after thrombectomy to detect complications
Cercare Medical and Siemens Healthineers today announced a global collaboration to accelerate the adoption of Cone-Beam CT Perfusion (CBCT-P) in acute stroke care and leverage its capability to show the flow of blood through the brain’s tissue and visualize how well different areas are being supplied with oxygen and nutrients. The joint solution combines the Cercare Medical Neurosuite (CMN), an integrated portfolio of advanced, vendor-neutral imaging software solutions that deliver automated perfusion analysis across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Cone-Beam CT with the Siemens Healthineers Syngo DynaCT Multiphase, a 3D acquisition protocol that enables up to ten CBCT angiography phases. The two solutions combined enable advanced perfusion and metabolic imaging directly in the angiography suite, helping clinicians diagnose stroke and during intervention reducing the need of transferring the patient from the angiography room to the imaging modality. This capability has the potential to streamline workflows and shorten the time to treatment, which is a critical factor for the outcome of stroke patients.
Stroke remains one of the leading causes of death and long term disability worldwide, with one in four adults expected to experience a stroke in their lifetime1. Because millions of neurons are lost each minute, rapid and accurate imaging is essential to guide treatment decisions. The solution supports immediate assessment of tissue viability during and after thrombectomy – including detection of distal occlusions, microvascular disturbances, and the no-reflow phenomenon. Cone-Beam CT Perfusion delivers near CT-like perfusion maps on angiography systems, providing clinicians with intra-procedural insight into both conventional perfusion parameters and advanced metabolic biomarkers2.
The scientific foundation of the solution has been established in close collaboration with Prof. Johannes Kaesmacher, MD, at Inselspital, Bern University Hospital, Switzerland. Additional projects are underway at three other leading hospitals. “You can only treat what you can see. CBCT perfusion delivers crucial insights right in the angio suite, when standard imaging like CT or MR is not immediately available,” said Prof. Kaesmacher. “This supports real-time imaging guided decision making in the acute phase of treatment. This includes the assessment of residual occlusions, no reflow, and complications as well as predicting brain tissue viability and clinical outcomes.”
Henrik Andersen, Chief Commercial Officer, Cercare Medical said: “This collaboration allows us to scale perfusion imaging globally. Through our standalone Cercare Medical Neurosuite offering, we can address perfusion-only opportunities while ensuring flexibility for stroke centers seeking advanced decision support directly in the angio suite.”
Carsten Bertram, head of Advanced Therapies at Siemens Healthineers, added: “By combining Cercare’s advanced perfusion software with our Syngo DynaCT technology, we deliver a comprehensive solution that supports clinicians to care for their patients across the full treatment pathway. Together, we are enabling a new standard in interventional stroke care.”
Further information can be found here: https://www.siemens-healthineers.com/angio/interventional-radiology/clinical-specialities/neuroradiology
